Back to discover
Drug
Poloxamer
Research stageEmerging research
Also known as Poloxamers.
1
Research papers
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this drug.
Research2018-07-17Nature communications
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Canonical name
Poloxamer
Aliases & brands
Poloxamers
RxNorm CUI
155156
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Most influential
Journals, researchers & institutions
Top journals
- Nature communications1
Leading researchers
- Guo B1
- Liang Y1
- Ma PX1
- Wu H1
- Zhao X1
Leading institutions
free-text, unnormalised
- Frontier Institute of Science and Technology and State Key Laboratory for Mechanical Behavior of Materials1
- Macromolecular Science and Engineering Center1
- the First Affiliated Hospital1
- University of Michigan1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 2 of the same disease areas as Poloxamer in the shared literature.
2 shared diseases1 shared paper
Studied across 2 of the same disease areas as Poloxamer in the shared literature.
2 shared diseases1 shared paper
References & data sources
- RxNorm (U.S. National Library of Medicine) — drug identity
- Europe PMC — research literature